We combined in vitro studies with the analysis of a high number of tumor samples from different CRC stages and confirmed that Cdk5 is involved in CRC progression and that it could serve as a prognostic and predictive biomarker in this disease. The gene discussed is CDK5; the disease is neoplasm.